Moreover, BCL9L is demonstrated to enhance β-catenin–mediated transcriptions and increase the abilities of proliferation and metastasis in breast and colon cancer cell lines (Brembeck et al., 2011; El-Hage et al., 2015). The gene discussed is BCL9L; the disease is malignant colon neoplasm.